Use of intraosseous hypertonic saline in critically ill patients

被引：6

作者：

Farrokh, Salia ^{[1
]}

Cho, Sung-Min ^{[2
]}

Lefebvre, Austen T. ^{[2
]}

Zink, Elizabeth K. ^{[2
]}

Schiavi, Adam ^{[2
,3
]}

Puttgen, Hans A. ^{[2
,3
]}

机构：

[1] Johns Hopkins Univ Hosp, Dept Pharm Crit Care & Surg Pharm, Neurosci Crit Care Unit, 600 North Wolfe St,Carnegie 180, Baltimore, MD 21287 USA

[2] Johns Hopkins Univ Hosp, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA

[3] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA

来源：

JOURNAL OF VASCULAR ACCESS | 2019年 / 20卷 / 04期

关键词：

Intraosseous; hypertonic saline; critical care; osmotic therapy; neurologic emergency; extravasation; TRAUMATIC BRAIN-INJURY; VASCULAR ACCESS; INTRACRANIAL HYPERTENSION; MANAGEMENT; INFUSION; PRESSURE;

D O I：

10.1177/1129729818805958

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Background: Rapid administration of hypertonic saline 23.4% is crucial in treatment of herniation syndromes. Hypertonic 23.4% saline must be administered via a central line. In cases where central line access is difficult to obtain and leads to delay in therapy, placement of intraosseous access can be lifesaving. Main body: The purpose of this case series is to describe the use of intraosseous administration of 23.4% saline in critically ill patients and to assess feasibility. Conclusion: Intraosseous administration of 23.4% saline in 6 adult patients with neurological emergencies was feasible and should be considered in cases where obtaining intravenous access is time consuming.

引用

页码：427 / 432

页数：6

共 50 条

[31] Hypertonic saline in neurocritical care: Is continuous infusion appropriate? [J].

Muizelaar, J. Paul ;

Shahlaie, Kiarash .

CRITICAL CARE MEDICINE, 2009, 37 (04) :1521-1523

[32] Use of exogenous erythropoietin in critically ill patients [J].

MacLaren, R ;

Gasper, J ;

Jung, R ;

Vandivier, RW .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (03) :195-208

[33] Cognitive impairment in critically ill patients and former critically ill patients: A concept analysis [J].

Hanifa, Ann Louise Bodker ;

Svenningsen, Helle ;

Moller, Annemaia Nadine ;

Dreyer, Pia ;

Holm, Anna .

AUSTRALIAN CRITICAL CARE, 2024, 37 (01) :166-175

[34] An Audit and Comparison of pH, Measured Concentration, and Particulate Matter in Mannitol and Hypertonic Saline Solutions [J].

Carr, Christopher J. ;

Scoville, Jonathan ;

Ruble, James ;

Condie, Chad ;

Davis, Gary ;

Floyd, Candace L. ;

Kelly, Logan ;

Monson, Ken ;

Reichert, Ethan ;

Sarigul, Buse ;

Hawryluk, Gregory W. J. .

FRONTIERS IN NEUROLOGY, 2021, 12

[35] Safety and Efficacy of Repeated Doses of 14.6 or 23.4 % Hypertonic Saline for Refractory Intracranial Hypertension [J].

Lewandowski-Belfer, Julie J. ;

Patel, Alden V. ;

Darracott, Robert M. ;

Jackson, Daniel A. ;

Nordeen, Jerah D. ;

Freeman, W. David .

NEUROCRITICAL CARE, 2014, 20 (03) :436-442

[36] Intravenous and Intraosseous Fluid Therapy in Critically Ill Birds of Prey [J].

Dube, Catherine ;

Dubois, Isabelle ;

Struthers, Jason .

JOURNAL OF EXOTIC PET MEDICINE, 2011, 20 (01) :21-26

[37] What's new in antimicrobial use and resistance in critically ill patients? [J].

Bassetti, Matteo ;

Nicolau, David P. ;

Calandra, Thierry .

INTENSIVE CARE MEDICINE, 2014, 40 (03) :422-426

[38] Cerebral edema: Hypertonic saline solutions [J].

Anish Bhardwaj ;

John A. Ulatowski .

Current Treatment Options in Neurology, 1999, 1 (3) :179-187

[39] Hypertonic Saline for the Treatment of Intracranial Hypertension [J].

Tareq Kheirbek ;

Jose L. Pascual .

Current Neurology and Neuroscience Reports, 2014, 14

[40] Contamination of hypertonic saline solutions in use by cystic fibrosis patients in Israel [J].

Peled, Orit ;

Kalamaro, Vardit ;

Kerem, Eitan ;

Shoseyov, David ;

Blau, Hannah ;

Efrati, Ori ;

Block, Colin .

JOURNAL OF CYSTIC FIBROSIS, 2014, 13 (05) :550-556

← 1 2 3 4 5 →